| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.26 | 0.09 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.33 | 0.09 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |